🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

New research shows that aging depletes NAD levels in T cells, compromising mitochondrial function and properties essential for CAR-T cell survival and efficacy >>> hubs.ly/Q03nXgKX0

What strategies can gene therapy manufacturers implement to address safety, efficacy and standardization challenges from the get-go? This spotlight feature provides robust standards for characterizing plasmid DNA, offering methodologies for mitigating risks in gene therapy

To conclude our Spotlight on gene therapy analytical testing, we revisited the feature highlights in this summary eBook. Delve into expert perspectives on current challenges and solutions, latest research findings and their practical applications, and forward-looking insights

Last Thursday, U.S. Pharmacopeia’s Senior Scientist II, Anthony Blaszczyk, and Stakeholder Engagement Manager, Bruno De Carvalho presented a webinar detailing their manufacturing standards for plasmid DNA. Register on-demand and catch-up on the session >>> hubs.ly/Q03jfgLK0

Last Thursday, U.S. Pharmacopeia’s Senior Scientist II, Anthony Blaszczyk, and Stakeholder Engagement Manager, Bruno De Carvalho presented a webinar detailing their manufacturing standards for plasmid DNA. Register on-demand and catch-up on the session >>> hubs.ly/Q03jfcqj0

How do you navigate the manufacturing process of quality plasmid-based therapies with limited industry standards? Standardization of plasmid DNA poses a crucial yet unaddressed challenge in cell and gene therapy development. In this infographic, we identify these challenges,

Accelerate the biopharma development pipeline! From viral vector characterization and cell line development to GMP manufacturing, Oxford Nanopore showcases the streamlining capabilities of its molecular sensing technology at every step of the therapeutic journey. Download the

Catch up on some of the latest news in just 5 minutes! This week: 🗞️BioIVT and Handok Biotech entered an agreement to offer BioIVT’s products in South Korea 🗞️RHEACELL and AOP Health Group joined forces to commercialize stem cell therapies 🗞️Medable launched a digital solution

This World Multiple Sclerosis day, we're highlighting the promise of regenerative medicine in tackling this unpredictable neurodegenerative disease. In our latest feature, we explore regenerative therapies that are being developed for multiple sclerosis, including: - Cell-based

In this webinar, Eppendorf’s Research Scientist Benjamin Wolters will share his insights on bioprocess data collaboration and the benefits of utilizing a platform for improving data accuracy and reducibility. Register now >>> hubs.ly/Q03bTSYf0

[INFOGRAPHIC] Addressing quality standards for plasmid DNA! This infographic explores how commercial standards and analytical guidelines are shaping the future of plasmid-based therapies. From quality control challenges to practical solutions, discover the benchmarks driving

[eBOOK] Gene therapy analytical testing! Download to discover expert perspectives on emerging solutions, research applications and industry trends shaping the future of gene therapy testing >>> hubs.ly/Q03pdp7z0

The U.S. FDA will be hosting a roundtable on cell and gene therapy, livestreaming TODAY, at 2pm-5pm BST / 9am-12pm ET, on YouTube and X. Some panelists include: Nicole Verdun (FDA), Carl June (University of Pennsylvania), Tim Hunt (Alliance for Regenerative Medicine), Catherine

📰 Cell and gene therapy news round up >>> hubs.ly/Q03qWz-80 This week: 💵 Akadeum Life Science closes a financing round following impressive data from the company’s proprietary platform 🤝 TQ Therapeutics GmbH acquires Juno Therapeutics GmbH, a subsidiary of Bristol

We want to learn more about industry opinions on gene therapy analytical testing! Share your insight about quality standards of plasmid DNA as gene therapy starting materials in this survey >>> hubs.ly/Q03hQ0Y80

This Gene Therapy Analytical Guide, provided by U.S. Pharmacopeia, is designed to help manufacturers of gene therapies establish a clear control strategy for assessing plasmid DNA used as a starting material. View now >>> hubs.ly/Q03hQcM50

What quality considerations should developers acknowledge for plasmid DNA when used as a starting material for cell and gene therapies? Find out from U.S. Pharmacopeia’s Senior Scientist II and Stakeholder Engagement Manager in this recent webinar >>> hubs.ly/Q03jfdtv0

Catch up on the latest news highlights on RegMedNet, including: 🗞️Capsida Biotherapeutics' IND approval 🗞️Capstan Therapeutics' in vivo CAR-T therapy for autoimmune disorders 🗞️SpliceBio's successful Series B funding round Get all the details >>> hubs.ly/Q03rRqVv0

Dive deep into plasmid DNA standardization for advanced therapies! From detailed process breakdowns to practical research applications, this downloadable eBook delivers insights to advance standardization in the field >>> hubs.ly/Q03pdskG0

This Spotlight explores the quality standards of plasmid DNA for gene therapy products. Dive into the key considerations for plasmid-based cell and gene therapy manufacturing, analytical characterizations, and standardized guidelines for sourcing, qualifying and testing plasmid